| Ernest Wooram Suh, PHARMD | |
|
5601 De Soto Ave, Woodland Hills, CA 91367-6701 | |
| (818) 719-3960 | |
| Not Available |
| Full Name | Ernest Wooram Suh |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 5601 De Soto Ave, Woodland Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033657713 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 69034 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ernest Wooram Suh, PHARMD 5601 De Soto Ave, Woodland Hills, CA 91367-6701 Ph: () - | Ernest Wooram Suh, PHARMD 5601 De Soto Ave, Woodland Hills, CA 91367-6701 Ph: (818) 719-3960 |
News Archive
Mazor Robotics Ltd., the developer of Renaissance, an innovative surgical guidance system and its complementary products, announced today that it has received its first order for a Renaissance system from Cordamed Biomedical Engineering Inc., its distribution partner in Turkey. This represents the first Renaissance system order in Turkey, and Cordamed will install the system at a prominent hospital in Istanbul.
U.S. medical schools have made significant progress to strengthen their management of clinical conflicts of interest, but a new study demonstrates that most schools still lag behind national standards. The Institute on Medicine as a Profession study, which compared changes in schools' policies in a dozen areas from 2008 to 2011, reveals that institutions are racing from the bottom to the middle, not to the top.
Health care professionals should focus on women's lifetime heart disease risk, not just short-term risk, according to updated American Heart Association guidelines.
Guidelines released on Monday by the U.S. Centers for Disease Control and Prevention, are designed to help track and alert the public to potentially deadly infections in hospitals and clinics.
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
› Verified 4 days ago
Dr. Sheta Ara, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21281 Burbank Blvd, Woodland Hills, CA 91367 Phone: 818-676-5990 | |
Yakov Suleymanov, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23357 Mulholland Dr, Woodland Hills, CA 91364 Phone: 818-223-8240 | |
Karin Y Cheng, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5601 De Soto Ave, Woodland Hills, CA 91367 Phone: 818-719-4050 Fax: 818-719-3507 | |
Dr. Diana Jamgotchian, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20940 Burbank Blvd, Home Infusion Pharmacy, Woodland Hills, CA 91367 Phone: 818-719-4300 | |
Dr. Sanam Holly Farokhi, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5601 De Soto Ave, Woodland Hills, CA 91367 Phone: 818-719-3435 | |
Dr. Ani Josephine Adamian, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5601 De Soto Ave, Woodland Hills, CA 91367 Phone: 818-719-4986 |